The global demand for Angioedema Treatment Market is presumed to reach the market size of nearly USD 12.31 BN by 2028 from USD 3.91 BN in 2021 with a CAGR of 17.8% under the study period 2022 - 2028.
Angioedema is rapid edema or swelling of the areas under the skin or mucous membranes. It commonly affects the arms, face, legs, airway and intestinal tract. It is usually an allergic reaction, but it can be genetic. Angioedema is caused by many factors, and in most cases, the exact cause is unknown. The major cause of angioedema is an allergic reaction, adverse effect of any medication, genetic defects, and infections.
Market Dynamics
The increasing cases of hereditary angioedema and related disorders such as appendicitis and gastrointestinal problems fuel the sales of angioedema treatment solutions. The growing awareness of the disease and its complications has made people take the treatment seriously, adopting the angioedema treatment solutions. Moreover, rising initiatives for improving awareness levels among the general population contribute to market growth. Furthermore, the approval of novel drugs in the past few years and promising pipeline drugs also fuel the global angioedema treatment market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of angioedema treatment. The growth and trends of angioedema treatment industry provide a holistic approach to this study.
Market Segmentation
This section of the angioedema treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Condition Type
- Allergic Angioedema
- Drug-Induced Angioedema
- Idiopathic Angioedema
- Hereditary Angioedema (HAE)
By Drug Type
- C1 Esterase Inhibitor (Cinryze, Berinert, Ruconest, Haegarda)
- Selective Bradykinin B2 Receptor Antagonist (Firazyr)
- Kallikrein Inhibitor (Kalbitor)
- Others
By Route Of Administration:
- Injection (Intravenous, Subcutaneous)
- Oral
By Distribution Channel
- Hospitals
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Angioedema Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Angioedema Treatment Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the angioedema treatment market include Shire plc, CSL Limited, Pharming Group NV, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
